Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC (Q66401645)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC |
clinical trial |
Statements
NEPTUN (English)
0 references
A Non-interventional Study of Nab-paclitaxel (Abraxane®) in Combination With Carboplatin as First Line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NEPTUN) (English)
0 references
29 August 2016
0 references
December 2019
0 references
408
0 references
18 year
0 references
99 year
0 references